Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early eradication of MRSA in cystic fibrosis
2013-000219-25Phase 3Active
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Staphylococcus aureus infection and cystic fibrosis (CF) comparing Rifampin + trimethoprim-sulfamethoxazole with Rifampin + minocycline (2 arms). Primary endpoint: Primary efficacy endpoint. Started Apr 2018; status: active.
02
Drugs
rifampicintrimethoprim + sulfamethoxazoleminocycline
03
Conditions
Staphylococcus aureus infectioncystic fibrosis (CF)
Beyond the preview
Go deeper on 2013-000219-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000219-25.